A Small Interfering RNA Screen of Genes Involved in DNA Repair Identifies Tumor-Specific Radiosensitization by POLQ Knockdown

A Small Interfering RNA Screen of Genes Involved in DNA Repair Identifies Tumor-Specific Radiosensitization by POLQ Knockdown

Afficher d'autres versions (1)

Détails bibliographiques
Auteurs principaux:	Higgins, G, Prevo, R, Lee, Y, Helleday, T, Muschel, R, Taylor, S, Yoshimura, M, Hickson, I, Bernhard, E, Mckenna, W
Format:	Journal article
Publié:	2010

Documents similaires

A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown.
par: Higgins, G, et autres
Publié: (2010)

POLQ (DNA polyermase theta) as a novel therapeutic target: preclinical and clinical data
par: Higgins, G, et autres
Publié: (2010)

Overexpression of POLQ confers a poor prognosis in early breast cancer patients.
par: Higgins, G, et autres
Publié: (2010)

NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity.
par: Fokas, E, et autres
Publié: (2012)

POLQ knockdown inhibits proliferation, migration, and invasion by inducing cell cycle arrest in colorectal cancer
par: Qing Yao, et autres
Publié: (2024-11-01)

Knockdown of POLQ interferes the development and progression of hepatocellular carcinoma through regulating cell proliferation, apoptosis and migration
par: Qi Pan, et autres
Publié: (2021-09-01)

NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity
par: Fokas Emmanouil, et autres
Publié: (2012-03-01)

Depletion of Signal Recognition Particle 72kDa increases radiosensitivity
par: Prevo, R, et autres
Publié: (2017)

Modifying radiosensitivity in tumors: Targeting the Ras-PI-3 kinase pathway.
par: Muschel, R, et autres
Publié: (2001)

Knockdown of ATRX enhances radiosensitivity in glioblastoma
par: Yue Zhao, et autres
Publié: (2024-06-01)

Gelsolin knockdown confers radiosensitivity to glioblastoma cells
par: Dezhi Gao, et autres
Publié: (2024-05-01)

A siRNA screen to identify molecular determinants of tumour radiosensitivity
par: Higgins, G, et autres
Publié: (2010)

POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma
par: Laura del Puerto-Nevado, et autres
Publié: (2024-10-01)

POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cells
par: Belan, O, et autres
Publié: (2022)

Dual loss of human POLQ and LIG4 abolishes random integration
par: Shinta Saito, et autres
Publié: (2017-07-01)

Circ_0062020 Knockdown Strengthens the Radiosensitivity of Prostate Cancer Cells
par: Li H, et autres
Publié: (2020-11-01)

Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells
par: Yanzhu Lin, et autres
Publié: (2019-05-01)

HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo.
par: Gupta, A, et autres
Publié: (2005)

TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy
par: Pirovano, G, et autres
Publié: (2017)

POLQ identifies a better response subset to immunotherapy in muscle‐invasive bladder cancer with high PD‐L1
par: Ge Liu, et autres
Publié: (2024-02-01)

Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines.
par: Kim, I, et autres
Publié: (2005)

Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity.
par: Prevo, R, et autres
Publié: (2008)

The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
par: Ashton, T, et autres
Publié: (2016)

Increasing radiosensitivity by alleviating tumour hypoxia: a drug screen reveals atovaquone as a clinical candidate
par: Ashton, T, et autres
Publié: (2016)

Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.
par: Fokas, E, et autres
Publié: (2012)

The influence of Ras pathway signaling on tumor radiosensitivity.
par: Kim, I, et autres
Publié: (2004)

Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922
par: Annett Kühnel, et autres
Publié: (2019-09-01)

Iron promotes ovarian cancer malignancy and advances platinum resistance by enhancing DNA repair via FTH1/FTL/POLQ/RAD51 axis
par: Qingyu Zhang, et autres
Publié: (2024-05-01)

CircROBO1 knockdown improves the radiosensitivity of hepatocellular carcinoma by regulating RAD21
par: Kai Yang, et autres
Publié: (2024-11-01)

Molecular radiosensitization of pancreatic carcinoma cell lines in vivo and in vitro
par: Cengel, K, et autres
Publié: (2004)

POLQ inhibition attenuates the stemness and ferroptosis resistance in gastric cancer cells via downregulation of dihydroorotate dehydrogenase
par: Yanmei Peng, et autres
Publié: (2024-04-01)

The clinical implications of gemcitabine radiosensitization.
par: Doyle, T, et autres
Publié: (2001)

SESN2 Knockdown Increases Betulinic Acid-Induced Radiosensitivity of Hypoxic Breast Cancer Cells
par: Antje Güttler, et autres
Publié: (2022-12-01)

Targeting ATR in DNA damage response and cancer therapeutics.
par: Fokas, E, et autres
Publié: (2014)

The effect of metformin and GANT61 combinations on the radiosensitivity of prostate cancer cells
par: Gonnissen, A, et autres
Publié: (2017)

The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
par: Thomas M. Ashton, et autres
Publié: (2016-07-01)

Polq-Mediated End Joining Is Essential for Surviving DNA Double-Strand Breaks during Early Zebrafish Development
par: Summer B. Thyme, et autres
Publié: (2016-04-01)

MSH2 stimulates interfering and inhibits non-interfering crossovers in response to genetic polymorphism
par: Julia Dluzewska, et autres
Publié: (2023-10-01)

Enhancing nasopharyngeal carcinoma cell radiosensitivity by suppressing AKT/mTOR via CENP-N knockdown
par: Li-Zhi Wu, et autres
Publié: (2023-11-01)

Targeting ATR in DNA damage response and cancer therapeutics
par: Fokas, E, et autres
Publié: (2014)